Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03710889 · ClinicalTrials.gov registry record · Phase 3
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
A Phase 3 study, sponsored by Radius Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
NCT03710889: Completed Phase 3 study, sponsored by Radius Health.
NCT03710889 is a Phase 3 study that has completed, run by Radius Health. The registered enrollment target is 23 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03710889, a Phase 3 study, has completed, sponsored by Radius Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
Study Summary
The objective of this study is to measure the early effects of abaloparatide on tissue-based bone formation using samples obtained by transiliac crest bone biopsy after quadruple fluorochrome labeling.
Primary Outcome
Change in dynamic histomorphometry indices was assessed in the cancellous envelope.
Interventions
- DRUG Abaloparatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-09-20 |
| Est. Completion | 2020-07-15 |
| Phase | Phase 3 |
What the finished NCT03710889 record still lists
NCT03710889 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Abaloparatide is the first listed.
NCT03710889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03710889 about?
NCT03710889 is a clinical study titled "Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption". The objective of this study is to measure the early effects of abaloparatide on tissue-based bone formation using samples obtained by transiliac crest bone biopsy after quadruple fluorochrome labeling.
What is the current status of trial NCT03710889?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2018-09-20. Estimated completion is 2020-07-15.
What interventions are being tested in trial NCT03710889?
The interventions under investigation include: Abaloparatide (DRUG).
Who is sponsoring clinical trial NCT03710889?
This trial is sponsored by Radius Health, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03710889's enrollment target sits among peer trials
23 1952nd of 2000 higher than 48 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI